sumMiRY Four cases of a polyneuropathy associated with pancreatitis and pancreatic pseudocyst fonnation are reported. Electrophysiological investigation showed the peripheral neuropathy to be predominantly axonal in type. These patients were all seriously ill and many factors may have been involved in the pathogenesis of their neuropathy. They had all received parenteral nutrition and multiple drug therapy including metronidazole, and all had severe sepsis. There was evidence that insufficient vitamin replacement had been given during total parenteral nutrition. It was not possible to decide whether the polyneuropathy resulted from the summation of these factors, is similar to what has been called the polyneuropathy of the critically ill, or is a new association with pancreatic disease.
Increasing surgical skill and the use of prolonged parenteral nutrition have enabled patients with severe pancreatic disease to be managed successfully. Unfortunately in the four cases reported here, a polyneuropathy developed during the course of the illness and its convalescent phase and delayed the patients' ultimate recovery. A neuropathy of the critically ill has recently been described' 2 Peripheral neuropathy complicating pancreatitis and major pancreatic surgery studies in all four cases would have been atypical in that there was evidence of predominant axonal degeneration, and clinically there was striking preservation of some upper limb reflexes. This diagnosis however remains a possibility for Case 3 especially in view of the absent F waves and associated facial diplegia.
All the patients received extended total parenteral nutrition over many months and the possibility remains that in some way this could be related to the neuropathic process. A standard regime of total parenteral nutrition was followed similar to that recommended in the British National Formulary.4 None of our patients developed diabetes with their total parenteral nutrition and pancreatitis although in two cases intravenous insulin was used in the postoperative period which led to intermittent hypoglycaemia in one case.
The table demonstrates the quantity of vitamin contained in Solivito (KabiVitrum) compared with the daily recommended minimum.'6 All four cases received considerably less vitamin replacement than that recommended as daily requirement and this assessment does not take into account the extra vitamin usage associated with sepsis, the large carbohydrate loads of parenteral nutrition and the possible degradation of the vitamin solution that then takes place. It is unlikely that thiamine deficiency alone was responsible for the neuropathy. The rapidity of onset after a relatively short period of vitamin depletion would be surprising. Also the neuropathies associated with vitamin B group deficiency tend to be sensory and painful, with the exception of that related to vitamin B12. The dominant non-painful motor involvement in three cases is thus a pointer against B vitamin deficiency as a primary cause. The amount of Vitalipid added was also less than the daily recommended minimum. There is no vitamin E in Vitalipid and that contained in Intralipid (soya oil) has only 10% activity. Unfortunately, vitamin E levels were not measured and we do not know if a deficiency state prevailed. It is probable that many patients with critical illness become vitamin depleted, particularly if vitamin replacement is not given from the onset of their hospital admission. We recommend that vitamin therapy should be greater than that regarded as the daily minimum required in normal people. In our patients this would have meant giving at least two ampoules of Solivito daily rather than the twice weekly regime that is recommended.4 It seems possible that the combination of pancreatic disease, vitamin deficiency, sepsis, metronidazole therapy and surgery together with short term glucose intolerance may have a summation effect. Alternatively, this may represent a new, previously unreported complication of severe pancreatic disease.
